Knockdown of MyD88 in activated B cell type (ABC) DLBCL cell lines causes a marked decrease in proliferation, this effect was shown to be dependent on the presence of oncogenic mutations [42]. The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.